- 1995
The use of intracerebral microdialysis to determine changes in blood-brain barrier transport characteristics,
Pharm Res, vol. 12, no. 1, pp. 129-33.
Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats,
Br J Pharmacol, vol. 114, no. 4, pp. 761-8.
Repeated microdialysis perfusions: periprobe tissue reactions and BBB permeability,
Brain Res, vol. 702, no. 1-2, pp. 261-5. DOI
The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain,
Pharm Res, vol. 12, no. 12, pp. 1924-31.
8-substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A1 receptor,
Eur J Pharmacol, vol. 290, no. 3, pp. 189-99.
Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline,
Br J Pharmacol, vol. 115, no. 7, pp. 1253-9.
Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of R- and S-N6-phenylisopropyladenosine in conscious normotensive rats,
J Pharmacol Exp Ther, vol. 273, no. 1, pp. 405-14.
Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivo,
Life Sci, vol. 57, no. 4, pp. 325-33. DOI
- 1994
Characterization of the pharmacodynamics of several antiepileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat,
J Pharmacol Exp Ther, vol. 269, no. 2, pp. 521-8.
Assessment of the enantiomeric purity of R- and S-N6-phenylisopropyladenosine (PIA): implications for adenosine receptor subclassification,
Naunyn Schmiedebergs Arch Pharmacol, vol. 350, no. 1, pp. 109-12.
Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat,
J Pharmacol Exp Ther, vol. 268, no. 2, pp. 616-24.
Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain,
Brain Res, vol. 666, no. 1, pp. 1-8.
Partial agonism of theophylline-7-riboside on adenosine receptors,
Naunyn Schmiedebergs Arch Pharmacol, vol. 350, no. 6, pp. 638-45.
Liquid chromatographic determination of the adenosine receptor agonist CGS 21680 in blood using on-line solid-phase extraction on a phenylboronic acid support and fluorescence detection,
J Chromatogr B Biomed Appl, vol. 658, no. 1, pp. 207-12.
Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home,
Ther Drug Monit, vol. 16, no. 4, pp. 341-8.
- 1993
Increased sensitivity to the anticonvulsant effect of valproate in aging BN/BiRij rats,
Pharm Res, vol. 10, no. 7, pp. 1046-51.
Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectives,
Eur J Drug Metab Pharmacokinet, vol. 18, no. 1, pp. 41-7.
Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system,
Pharm World Sci, vol. 15, no. 1, pp. 2-9.
A comparison of the concentration-effect relationships of midazolam for EEG-derived parameters and saccadic peak velocity,
Br J Clin Pharmacol, vol. 36, no. 2, pp. 109-15.
The use of intracerebral microdialysis to study blood-brain barrier transport in health, after modification and in disease,
Adv Exp Med Biol, vol. 331, pp. 257-62.
- 1992
Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs,
Clin Pharmacokinet, vol. 23, no. 3, pp. 191-215.
Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats,
Br J Pharmacol, vol. 107, no. 1, pp. 171-7.
Pharmacodynamics of the anticonvulsant effect of oxazepam in aging BN/BiRij rats,
Br J Pharmacol, vol. 107, no. 1, pp. 165-70.
Drug transport across the blood--brain barrier. I. Anatomical and physiological aspects,
Pharm Weekbl Sci, vol. 14, no. 5, pp. 305-10.


